Bioniz Therapeutics' Series A Round

Bioniz Therapeutics raised a round of funding on December 30, 2015. Investors include Cota Capital.

Bioniz is a biopharmaceutical company leading the discovery and development of first-in-class multiple-cytokine inhibitory therapeutics to address immuno-inflammatory diseases and cancer, with an init…

Articles about Bioniz Therapeutics' Series A Round: